|
Other anticoagulants
Citations 11-20 of 33 total displayed.
|
Past content
(since Nov 2000):
|
- Original Contributions
Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trials
- Gary A. Ford, Anna Maria Choy, Prakash Deedwania, Dean G. Karalis, Carl-Johan Lindholm, Wladyslaw Pluta, Lars Frison, S. Bertil Olsson on behalf of the SPORTIF III, V Investigators
Stroke 2007;38:2965-2971; published online before print as doi:10.1161/STROKEAHA.107.488007
[Abstract]
[Full text]
- Articles
Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation. Experience From the SPORTIF III and V Trials
- Gary A. Ford, Anna Maria Choy, Prakash Deedwania, Dean G. Karalis, Carl-Johan Lindholm, Wladyslaw Pluta, Lars Frison, S. Bertil Olsson SPORTIF III, V Investigators
Stroke published September 20, 2007, doi:10.1161/STROKEAHA.107.488007
[Abstract]
- Editorials
Predicting Stroke Risk in Patients With Atrial Fibrillation
- Daniel G. Hackam
Stroke 2007;38:2409; published online before print as doi:10.1161/STROKEAHA.107.488114
[Full text]
- Original Contributions
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
- Lawrence Baruch, Brian F. Gage, Jay Horrow, Steen Juul-Möller, Arthur Labovitz, Maria Persson, and Miguel Zabalgoitia
Stroke 2007;38:2459-2463; published online before print as doi:10.1161/STROKEAHA.106.477133
[Abstract]
[Full text]
- Articles
Predicting Stroke Risk in Patients With Atrial Fibrillation
- Daniel G. Hackam
Stroke published August 2, 2007, doi:10.1161/STROKEAHA.107.488114
[Abstract]
- Articles
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
- Lawrence Baruch, Brian F. Gage, Jay Horrow, Steen Juul-Möller, Arthur Labovitz, Maria Persson, and Miguel Zabalgoitia
Stroke published August 2, 2007, doi:10.1161/STROKEAHA.106.477133
[Abstract]
- Original Contributions
Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
- Paul T. Akins, Harvey A. Feldman, Robert G. Zoble, David Newman, Stefan G. Spitzer, Hans-Christoph Diener, and Gregory W. Albers
Stroke 2007;38:874-880; published online before print as doi:10.1161/01.STR.0000258004.64840.0b
[Abstract]
[Full text]
- Articles
Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation. Pooled Analysis of SPORTIF III and V Clinical Trials
- Paul T. Akins, Harvey A. Feldman, Robert G. Zoble, David Newman, Stefan G. Spitzer, Hans-Christoph Diener, and Gregory W. Albers
Stroke published January 25, 2007, doi:10.1161/01.STR.0000258004.64840.0b
[Abstract]
- Cochrane Corner
Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfractionated Heparin for Acute Ischemic Stroke
- Graeme J. Hankey, P. Sandercock, C. Counsell, and S.L. Stobbs
Stroke 2005;36:2045-2046; published online before print as doi:10.1161/01.STR.0000176587.45249.50
[Full text]
- Articles
Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfractionated Heparin for Acute Ischemic Stroke
- P. Sandercock, C. Counsell, and S. L. Stobbs
Stroke published August 18, 2005, doi:10.1161/01.STR.0000176587.45249.50
[Abstract]
|
|
